0001226555-16-000002.txt : 20160112 0001226555-16-000002.hdr.sgml : 20160112 20160112140147 ACCESSION NUMBER: 0001226555-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160112 DATE AS OF CHANGE: 20160112 EFFECTIVENESS DATE: 20160112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICONIC THERAPEUTICS INC CENTRAL INDEX KEY: 0001226555 IRS NUMBER: 161653625 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-254964 FILM NUMBER: 161338384 BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 515 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-437-1000 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 515 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0707 D LIVE 0001226555 ICONIC THERAPEUTICS INC 395 Oyster Point Boulevard Suite 515 South San Francisco CA CALIFORNIA 94080 650-437-1000 DELAWARE None None Corporation true William Greene 395 Oyster Point Boulevard Suite 515 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Kirk Dornbush 395 Oyster Point Boulevard Suite 515 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Todd Foley 395 Oyster Point Boulevard Suite 515 South San Francisco CA CALIFORNIA 94080 Director Johan Kordel 395 Oyster Point Boulevard Suite 515 South San Francisco CA CALIFORNIA 94080 Director Bruce Robertson 395 Oyster Point Boulevard Suite 515 South San Francisco CA CALIFORNIA 94080 Director Peter Hirth 395 Oyster Point Boulevard Suite 515 South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2015-12-24 false true true Series C-1 Preferred Stock; Common Stock issuable upon conversion false 0 43000000 38000000 5000000 false 8 0 0 500000 true Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. false ICONIC THERAPEUTICS INC /s/ William L. Greene William L. Greene CEO 2016-01-11